Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Hosny Salama, Pravin Punamiya, Andrew de la Torre, Michael Lange, Hassan Ahmed, Ismail Elchagie, Abdel Rahman Zekri, Eman Medhat, Abeer Bahnasi, Mohammed Rabbat
  • Journal of Hepatocellular Carcinoma, June 2015, Dove Medical Press
  • DOI: 10.2147/jhc.s60864

Ambovex Article

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/jhc.s60864

The following have contributed to this page: Dr Pravin A Punamiya and Andrew N de la Torre